<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id><journal-id journal-id-type="publisher-id">MEDI</journal-id><journal-title-group><journal-title>Medicine</journal-title></journal-title-group><issn pub-type="ppub">0025-7974</issn><issn pub-type="epub">1536-5964</issn><publisher><publisher-name>Wolters Kluwer Health</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29069041</article-id><article-id pub-id-type="pmc">5671874</article-id><article-id pub-id-type="publisher-id">MD-D-17-01863</article-id><article-id pub-id-type="doi">10.1097/MD.0000000000008418</article-id><article-id pub-id-type="art-access-id">08418</article-id><article-categories><subj-group subj-group-type="heading"><subject>5500</subject></subj-group><subj-group><subject>Research Article</subject><subject>Clinical Trial/Experimental Study</subject></subj-group></article-categories><title-group><article-title>Effects of fiber and probiotics on diarrhea associated with enteral nutrition in gastric cancer patients</article-title><subtitle>A prospective randomized and controlled trial</subtitle></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Rui</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yong</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Yuqian</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cui</surname><given-names>Yaping</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Xia</surname><given-names>Lin</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rao</surname><given-names>Zhiyong</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Yong</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref rid="cor1" ref-type="corresp"><sup>&#x02217;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Xiaoting</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref rid="cor1" ref-type="corresp"><sup>&#x02217;</sup></xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Iriti.</surname><given-names>Marcello</given-names></name></contrib></contrib-group><aff id="aff1"><label>a</label>Department of Gastrointestinal Surgery, West China Hospital, Sichuan University</aff><aff id="aff2"><label>b</label>Department of Clinical Nutrition, West China Hospital, Sichuan University, Chengdu, China.</aff><author-notes id="cor1"><corresp><label>&#x02217;</label>Correspondence: Yong Zhou, and Xiaoting Wu, Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, 37 Guo Xue Road, Chengdu, Sichuan Province 610041, China (e-mails: <email>nutritioner@hotmail.com</email>, <email>wxt1@medmail.com.cn</email>).</corresp></author-notes><pub-date pub-type="collection"><month>10</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>27</day><month>10</month><year>2017</year></pub-date><volume>96</volume><issue>43</issue><elocation-id>e8418</elocation-id><history><date date-type="received"><day>31</day><month>3</month><year>2017</year></date><date date-type="rev-recd"><day>29</day><month>9</month><year>2017</year></date><date date-type="accepted"><day>2</day><month>10</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 the Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nd/4.0"><license-p>This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nd/4.0">http://creativecommons.org/licenses/by-nd/4.0</ext-link></license-p></license></permissions><self-uri xlink:type="simple" xlink:href="medi-96-e8418.pdf"/><abstract><title>Abstract</title><sec sec-type="background"><title>Background and objectives:</title><p>Diarrhea is a common complication of enteral nutrition (EN), which affects recovery and prolongs the length of hospital stay (LOHS). To investigate the effect of fiber and probiotics in reducing diarrhea associated with EN in postoperative patients with gastric cancer (GC), the authors designed this prospective randomized-controlled trial.</p></sec><sec sec-type="methods"><title>Methods and study design:</title><p>This study included 120 patients with GC, and the patients were classified into 3 groups via random picking of envelopes: fiber-free nutrition formula (FF group, n&#x0200a;=&#x0200a;40), fiber-enriched nutrition formula (FE group, n&#x0200a;=&#x0200a;40), and fiber- and probiotic-enriched nutrition formula (FEP group, n&#x0200a;=&#x0200a;40). All patients were given EN formulas for 7 consecutive days after surgery.</p></sec><sec sec-type="results"><title>Results:</title><p>The number of diarrhea cases was higher in the FF group than in the FE group (<italic>P</italic>&#x0200a;=&#x0200a;.007). The FEP group had a lower number of diarrhea cases compared with the FE group (<italic>P</italic>&#x0200a;=&#x0200a;.003). Patients in the FE group had a significantly shorter first flatus time than the FF group (<italic>P</italic>&#x0200a;=&#x0200a;.002). However, no significant difference was observed between the FE group and FEP group (<italic>P</italic>&#x0200a;=&#x0200a;.30). Intestinal disorders were similar between the FE group and FF group (<italic>P</italic>&#x0200a;=&#x0200a;.38). The FEP group had a lower number of intestinal disorder cases than the FF group (<italic>P</italic>&#x0200a;=&#x0200a;.03). LOHS in the FE and FEP groups was shorter than that in the FF group (<italic>P</italic>&#x0200a;=&#x0200a;.004; <italic>P</italic>&#x0200a;&#x0003c;&#x0200a;.001). However, no significant difference was observed between the FE and FEP groups (<italic>P</italic>&#x0200a;=&#x0200a;.28). In addition, no significant difference was observed between the 3 groups in terms of total lymphocyte count, albumin, prealbumin, and transferrin levels on day 7 of enteral feeding.</p></sec><sec sec-type="conclusion"><title>Conclusions:</title><p>The combination of fiber and probiotics was significantly effective in treating diarrhea that is associated with EN in postoperative patients with GC.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>diarrhea</kwd><kwd>enteral nutrition</kwd><kwd>fiber</kwd><kwd>gastric cancer</kwd><kwd>probiotics</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><label>1</label><title>Introduction</title><p>Gastric cancer (GC) is the 4th most common type of cancer worldwide, and more than 50% of cases occur in Eastern Asia.<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> Malnutrition is prevalent in patients with GC, which can increase the risk of mortality and morbidity in perioperative patients with GC.<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup> Enteral nutrition (EN) is a recommended nutrition support for patients with GC (Grade A) after surgery.<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup> A prospective multicenter randomized-controlled trial (RCT) showed that EN could preserve intestinal structure and function, enhance intestinal-mediated immunity, and shorten the length of hospital stay (LOHS).<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup> However, EN can also cause some complications.<sup>[<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref>]</sup> Among the complications, diarrhea is common and the most prevalent, and it can affect the overall recovery of postoperative patients with GC, causing fluid and electrolyte loss, which results in intestinal disorders, ultimately prolonging the LOHS, and even increasing mortality and morbidity.<sup>[<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref>]</sup> Numerous studies reported that the prevalence rate of diarrhea in patients who were receiving EN was between 12% and 68%.<sup>[<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref>]</sup> Therefore, reducing diarrhea that is associated with EN is critical in enhancing recovery and shortening the LOHS in patients with GC after gastrectomy.</p><p>Several factors that are involved in the pathogenesis of diarrhea that is associated with EN were observed.<sup>[<xref rid="R11" ref-type="bibr">11</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref>]</sup> One of the risk factors was intestinal flora imbalance. Previous studies have shown that intestinal flora imbalance occurred in patients with diarrhea that is associated with EN and might be involved in its pathogenesis.<sup>[<xref rid="R14" ref-type="bibr">14</xref>]</sup> Whelan showed that bifidobacteria, one of the main probiotics in the intestinal flora, can vary by 1000-fold in patients who are receiving EN.<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup> Patients who experience diarrhea during EN had a low level of bifidobacteria in the intestinal flora, and these patients also had a high level of clostridia, which are the pathogenic bacteria that causes diarrhea.<sup>[<xref rid="R16" ref-type="bibr">16</xref>]</sup> Intestinal flora imbalance can affect intestinal function, resulting in diarrhea, vomiting/nausea, abdominal distension, and abdominal pain.</p><p>Some studies reported that fiber-based enteral formulas could help reduce diarrhea that is associated with EN.<sup>[<xref rid="R17" ref-type="bibr">17</xref>&#x02013;<xref rid="R19" ref-type="bibr">19</xref>]</sup> However, a systematic review concluded that evidence on this association was insufficient.<sup>[<xref rid="R20" ref-type="bibr">20</xref>]</sup> Our previous meta-analysis also had the same conclusion.<sup>[<xref rid="R21" ref-type="bibr">21</xref>]</sup> Meanwhile, over the years, probiotics had been extensively studied, and several beneficial effects had been discovered, such as protection against colonization by pathogenic bacteria, regulation of the immune system, and enhancement of intestinal barrier function.<sup>[<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref>]</sup> In the recent years, the use of probiotics as a treatment for various kinds of severe diarrhea has been increasing.<sup>[<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R25" ref-type="bibr">25</xref>]</sup> However, some studies reported that probiotics were not effective in preventing diarrhea.<sup>[<xref rid="R26" ref-type="bibr">26</xref>&#x02013;<xref rid="R28" ref-type="bibr">28</xref>]</sup> Guidelines on the use of fiber or/and probiotics in the treatment of diarrhea that is associated with EN are conflicting. To investigate the effect of fiber or/and probiotics on diarrhea that is associated with EN in postoperative patients with GC, we designed this prospective RCT.</p></sec><sec><label>2</label><title>Materials and methods</title><sec><label>2.1</label><title>Patients</title><p>This RCT included 120 patients based on the guidelines and power calculation of previous studies (NCSS-PASS 11). All patients were confirmed to have GC via pathological diagnosis, and they underwent distal gastrectomy between October 2015 and October 2016 in West China Hospital, Sichuan University. All the patients had stage II or III tumors (NCCN Guideline for Gastric Cancer 2016), and this was confirmed via preoperative computed tomography. In addition, these tumors were assessed and completely resected by 2 experienced surgeons. The inclusion criteria were as follows: patients aged 18 to 80 years of either gender and those who did not receive neoadjuvant chemotherapy or whose expected lifetime is longer than 6 months. The exclusion criteria were as follows: patients with diarrhea, hepatic, renal, or cardiac dysfunction, sepsis, or a history of drug abuse; those who were receiving enteral or parenteral nutritional support before surgery; those with contraindications to EN; and those who were taking broad-spectrum antibiotics before surgery. All patients who met the criteria were randomly classified into 3 treatment groups by picking sealed numbered envelopes: fiber-free nutrition formula (FF group, n&#x0200a;=&#x0200a;40), fiber-enriched nutrition formula (FE group, n&#x0200a;=&#x0200a;40), and fiber- and probiotic-enriched nutrition formula (FEP group, n&#x0200a;=&#x0200a;40) for better readability and conciseness. We assessed the baseline characteristics of the patients, including age, sex, body mass index (BMI), and cancer stage, according to the tumor-node-metastasis classification of the International Union against Cancer (7th edition), American Society of Anesthesiologists (ASA) score, and results of total lymphocyte count (TLC), albumin (ALB), prealbumin (PA), and transferrin (TRF) tests.<sup>[<xref rid="R29" ref-type="bibr">29</xref>]</sup></p></sec><sec><label>2.2</label><title>Study design</title><p>For all patients who underwent their respective procedure, an enteral feeding tube was inserted into the first jejunal loop 15 to 20&#x0200a;cm below the lowest intestinal anastomosis by a surgeon and anesthesiologist at the time of operation. Early EN that was based on the ESPEN guideline was initiated on day 1 after surgery using an enteral feeding tube.<sup>[<xref rid="R30" ref-type="bibr">30</xref>]</sup> Each group received nutritional support with daily EN dose of EN emulsion (Sino-Swed Pharmaceutical Corp. Ltd, Beijing, China) (FF group); EN emulsion and Shen Jia (Beijing Tiantian Yikang Biological Technology Corp. Ltd, Beijing, China) (FE group); EN suspension, Shen Jia, and a combination of live bifidobacterium and lactobacillus in tablets (Inner Mongolia Shuangqi Pharmaceutical Corp. Ltd, Beijing, China) (FEP group). No differences were observed between the FF group and FE group in terms of EN with fiber intake. In addition, a difference was observed between the FE group and FEP group in terms of EN with probiotic intake. After 2 days, all patients only received 500&#x0200a;mL of EN per day. On day 3, patients began to receive 1500&#x0200a;mL of EN until the procedure ended. All patients were given EN support for 7 consecutive days after surgery, and their total caloric intake everyday should reach 125.52&#x0200a;kJ (30 kcal)/kg. If energy intake via EN was insufficient, residual energy will be obtained by the infusion of 10% glucose and normal saline infusion (Fig. <xref ref-type="fig" rid="F1">1</xref>). Fecal output was monitored by a nursing staff using the King's Stool Chart.<sup>[<xref rid="R31" ref-type="bibr">31</xref>]</sup> The definition and standard were as follows: Fecal score was assessed according to a score defined by the King's Stool Chart. The chart incorporates descriptors of fecal frequency, weight, and consistency. Each fecal of the patient was scored, and the sum of the scores within 24&#x0200a;h was considered as the fecal score of the patient. Diarrhea is classified by a daily fecal score of 15 or higher.<sup>[<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R32" ref-type="bibr">32</xref>]</sup> On days 1, 3, 5, and 7 after surgery, TLC, ALB, PA, and TRF tests were carried out, which are the indicators of the nutrition status of the patients. On day 8, that marks the endpoint of the RCT, it was decided whether EN is continued. LOHS and intestinal function recovery, such as abdominal pain, vomiting/nausea, anastomotic fistula, and abdominal distension, were expressed in days, and the duration of the first fecal was recorded.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Randomized-controlled trial profile.</p></caption><graphic xlink:href="medi-96-e8418-g001"/></fig></sec><sec><label>2.3</label><title>Ethics statement</title><p>The study protocol was approved by the ethics committee of Sichuan University, West China Hospital. A written informed consent was obtained from the patients before the start of the study. The analysis did not involve interaction with human participants or the use of personal identifying information. Patient records/information was anonymized and deidentified prior to analysis, and the methods were performed in accordance with the approved guidelines.</p></sec><sec><label>2.4</label><title>Statistical analysis</title><p>Categorical variables were reported as counts and percentages. Continuous variables were reported as mean and standard deviations. Categorical variables were estimated via chi-squared test and Fisher exact test. Continuous variables were compared across the 3 groups using 1-way analysis of variance. Changes and differences between the 2 groups were assessed via <italic>t</italic> tests. The statistical package SPSS 20.0 for Windows (IBM, Beijing) was used for the statistical analysis. A <italic>P</italic> value &#x0003c; .05 was considered statistically significant.</p></sec></sec><sec><label>3</label><title>Results</title><p>A total of 120 patients were included in this RCT. After the initiation of the study, none of the patients were excluded because of severe complications or EN intolerance. No difference was observed between the 3 groups in terms of age, sex, weight, BMI, ASA score, nutrition status, and cancer stage (Table <xref ref-type="table" rid="T1">1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Patients&#x02019; characteristics.</p></caption><graphic xlink:href="medi-96-e8418-g002"/></table-wrap><p>When the total number of diarrhea cases was recorded, the same patient cannot be recorded again. In the FF group, 24 patients (60%) had diarrhea for 7 days, whereas 12 (30%) and 2 (5%) patients from the FE and FEP groups had diarrhea, respectively. No significant difference was observed between the 3 groups in terms of the number of diarrhea cases (&#x003c7;<sup>2</sup>&#x0200a;=&#x0200a;28.0; <italic>P</italic>&#x0200a;&#x0003c;&#x0200a;.001). The number of diarrhea cases in the FF group was higher than that of the FE group (&#x003c7;<sup>2</sup>&#x0200a;=&#x0200a;7.3; <italic>P</italic>&#x0200a;=&#x0200a;.007) (Table <xref ref-type="table" rid="T2">2</xref>). The FEP group had a lower number of diarrhea cases compared with the FE group (&#x003c7;<sup>2</sup>&#x0200a;=&#x0200a;8.7; <italic>P</italic>&#x0200a;=&#x0200a;.003) (Table <xref ref-type="table" rid="T2">2</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Number of diarrhea cases in the 3 groups.</p></caption><graphic xlink:href="medi-96-e8418-g003"/></table-wrap><p>Patients in the FE group had a significantly shorter first flatus time than the FF group (<italic>P</italic>&#x0200a;=&#x0200a;.002), whereas that of the FE and FEP groups did not differ (<italic>P</italic>&#x0200a;=&#x0200a;.300). However, intestinal disorders, such as abdominal pain, vomiting/nausea, and abdominal distension, were similar in the 3 groups. However, a lower number of intestinal disorder cases was observed in the FEP group than the FF group (<italic>P</italic>&#x0200a;=&#x0200a;.026) (Table <xref ref-type="table" rid="T3">3</xref>). LOHS in the FE and FEP groups was shorter than that in the FF group (<italic>P</italic>&#x0200a;=&#x0200a;.004 and <italic>P</italic>&#x0200a;&#x0003c;&#x0200a;.001). However, no significant difference was observed between the FE group and FEP group (<italic>P</italic>&#x0200a;=&#x0200a;.277).</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Postoperative recovery of patients.</p></caption><graphic xlink:href="medi-96-e8418-g004"/></table-wrap><p>The levels of TLC, ALB, PA, and TRF on the 7th day were not significantly different between the 3 groups (Table <xref ref-type="table" rid="T3">3</xref>).</p></sec><sec><label>4</label><title>Discussion</title><p>Previous studies reported that adding fiber or probiotics could maintain intestinal microecology that decrease diarrhea that is associated with EN.<sup>[<xref rid="R33" ref-type="bibr">33</xref>]</sup> However, the effect of the combination of fiber and probiotics on treating diarrhea was inconclusive.<sup>[<xref rid="R34" ref-type="bibr">34</xref>&#x02013;<xref rid="R36" ref-type="bibr">36</xref>]</sup> This RCT study showed that the combination of fiber and probiotics could be the most effective method in treating diarrhea that is associated with EN in postoperative patients with GC.</p><p>The addition of fiber to EN formulas was effective in preventing diarrhea that is associated with EN compared with fiber-free EN formulas.<sup>[<xref rid="R37" ref-type="bibr">37</xref>]</sup> This RCT study also confirmed this standpoint by comparing the FF and FE groups (<italic>P</italic>&#x0200a;=&#x0200a;.007) (Table <xref ref-type="table" rid="T2">2</xref>). Fiber is a general term for a type of carbohydrates that cannot be used by humans. Numerous kinds of fiber are available based on different characteristics, which play different roles in reducing diarrhea, such as increasing fecal bulk, normalizing intestinal flora, and holding water.<sup>[<xref rid="R38" ref-type="bibr">38</xref>&#x02013;<xref rid="R41" ref-type="bibr">41</xref>]</sup> Fiber parts can be metabolized by intestinal flora and produce short-chain fatty acids (SCFAs), butyrate, acetate, and propionate, which are the preferred source of energy of colonic cells to improve gut barrier function.<sup>[<xref rid="R41" ref-type="bibr">41</xref>,<xref rid="R42" ref-type="bibr">42</xref>]</sup> The SCFAs can stimulate colonic water absorption and help maintain an environment with a low pH for the colonic flora to prevent enteropathogenic infections, such as those caused by <italic>Clostridium difficile</italic>.<sup>[<xref rid="R43" ref-type="bibr">43</xref>,<xref rid="R44" ref-type="bibr">44</xref>]</sup> Some fibers can be fermented in the colon and result in the selective growth of beneficial bacteria, such as the stimulation of selective bifidobacterial growth.<sup>[<xref rid="R37" ref-type="bibr">37</xref>,<xref rid="R45" ref-type="bibr">45</xref>]</sup></p><p>The outcome in the FEP group was more favorable than that in the other groups, showing that the combination of fiber and probiotics was effective in the treatment of diarrhea that is associated with EN (Table <xref ref-type="table" rid="T2">2</xref>). Several factors are involved in the pathogenesis of diarrhea in which the disruption of intestinal flora can play a key role. Intestinal flora can affect a variety of intestinal functions, such as the maintenance of the integrity of the epithelial barrier and the development of mucosal immunity. Meanwhile, intestinal flora can also produce a variety of substances, ranging from relatively nonspecific fatty acids and peroxides to highly specific bacteriocins, which can inhibit or kill other potentially pathogenic bacteria.<sup>[<xref rid="R46" ref-type="bibr">46</xref>,<xref rid="R47" ref-type="bibr">47</xref>]</sup> Previous studies had shown that the presence of intestinal flora while receiving EN can be a disorder, of which the most remarkable change is the existence of bifidobacteria and lactobacillus.<sup>[<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref>]</sup> Standard fiber-free EN formulas can cause higher production of aerobes, reduce the number of butyrate-producing bacteria, and decrease colonic flora levels, particularly in the presence of bifidobacteria and lactobacillus.<sup>[<xref rid="R48" ref-type="bibr">48</xref>]</sup> Lactobacillus can ferment fiber to generate lactic acid, which is the major end product, whereas bifidobacteria are important producers of SCFAs.<sup>[<xref rid="R49" ref-type="bibr">49</xref>]</sup> Lactobacillus and bifidobacteria can remain as stable elements of the normal intestinal microbiota, and dysbiosis is associated with pathological conditions.<sup>[<xref rid="R50" ref-type="bibr">50</xref>]</sup> Historically, the most usual application of probiotics was for the treatment of gastrointestinal disorders, particularly diarrhea.<sup>[<xref rid="R51" ref-type="bibr">51</xref>]</sup> Its application can prevent diarrhea that is associated with EN by competing with enteropathogenic infection and fermenting fiber.</p><p>The present RCT study also found the result on the recovery of patients who were affected by fiber and probiotics as shown in Table <xref ref-type="table" rid="T3">3</xref>. Patients in the FE group had a significantly shorter first flatus time than those in the FF group (<italic>P</italic>&#x0200a;=&#x0200a;.002). Fiber could accelerate intestinal movement and shorten the duration of the first flatus. Fibers could improve fecal passage management by ameliorating small intestinal mucosal atrophy, which would enhance patient recovery after GC surgery.<sup>[<xref rid="R52" ref-type="bibr">52</xref>]</sup> However, fiber might increase intestinal disorders, even though no significant difference was observed between the FE group and FEP group because of the small sample size (Table <xref ref-type="table" rid="T3">3</xref>). GC surgery and antibiotics most likely caused postoperative intestinal flora imbalance, and fiber was not sufficiently fermented, resulting in abdominal pain, vomiting/nausea, and abdominal distension.<sup>[<xref rid="R53" ref-type="bibr">53</xref>,<xref rid="R54" ref-type="bibr">54</xref>]</sup> The LOHS of the FE and FEP groups was shorter than that of the FF group, and this result was also reported by previous researchers,<sup>[<xref rid="R55" ref-type="bibr">55</xref>,<xref rid="R56" ref-type="bibr">56</xref>]</sup> which was in accordance with the current requirements of enhanced recovery after surgery (ERAS).<sup>[<xref rid="R31" ref-type="bibr">31</xref>]</sup> Based on the results of LOHS and intestinal disorders in the 3 groups, the combination fiber and probiotics can treat diarrhea that is associated with EN and enhance patient recovery after GC surgery.</p><p>No significant difference was observed among the 3 groups in terms of nutritional status (Table <xref ref-type="table" rid="T4">4</xref>). Nutritional support of the patients with diarrhea was most likely not interrupted by severe diarrhea. In addition, this RCT study might was conducted for a short period of time, and the change in nutrition status was not clearly shown.</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Comparison of the nutrition indexes of the 3 groups.</p></caption><graphic xlink:href="medi-96-e8418-g005"/></table-wrap><p>This study has several limitations, considering the interpretation time of the study results. First, although all the patients participated until the end of the trial, its sample size was still small (120 patients), which is considered as the major limitation of the study. Second, the study did not use double blind trial to avoid the loss of samples. Because of ERAS, our observation time was short, which might affect some of the observed indicators, particularly nutritional status.</p></sec><sec><label>5</label><title>Conclusion</title><p>Based on this RCT study, the combination of fiber and probiotics could reduce the incidence of diarrhea, enhance intestinal movement, and decrease the intestinal disorders in postoperative patients with GC who are on EN. In addition, this treatment can shorten the LOHS, which was in accordance with the current requirements of ERAS. Thus, the use of both fiber and probiotics should be considered when initiating EN to avoid diarrhea that is associated with EN, provide comfort for postoperative patients, and enhance patient recovery after surgery.</p></sec><sec><title>Acknowledgment</title><p>The authors would like to thank the nursing and support staff at West China Hospital of Sichuan University.</p></sec></body><back><fn-group><fn fn-type="abbr"><p>Abbreviations: ALB = albumin, BMI = body mass index, EN = enteral nutrition, ERAS = enhanced recovery after surgery, FE = fiber-enriched nutrition formula, FEP = fiber- and probiotic-enriched nutrition formula, FF = fiber-free nutrition formula, GC = gastric cancer, LOHS = length of hospital stay, PA = prealbumin, RCT = randomized-controlled trial, TLC = total lymphocyte count, TRF = transferrin.</p></fn><fn fn-type="other"><p>YZ and RZ designed the study. All the authors contributed to the research and development of the manuscript. RZ wrote the manuscript under the guidance of YZ. All the authors have read the manuscript, and YZ and XW approved the final manuscript.</p></fn><fn fn-type="supported-by"><p>This study was supported by Sichuan Provincial Science and Technology Support Project (2016SZ0047).</p></fn><fn fn-type="COI-statement"><p>The authors have no conflicts of interest to disclose.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Miller</surname><given-names>KD</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group>
<article-title>Cancer statistics, 2016</article-title>. <source>CA Cancer J Clin</source>
<year>2016</year>;<volume>66</volume>:<fpage>7</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">26742998</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heneghan</surname><given-names>HM</given-names></name><name><surname>Zaborowski</surname><given-names>A</given-names></name><name><surname>Fanning</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Prospective study of malabsorption and malnutrition after esophageal and gastric cancer surgery</article-title>. <source>Ann Surg</source>
<year>2015</year>;<volume>262</volume>:<fpage>803</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">26583669</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weimann</surname><given-names>A</given-names></name><name><surname>Braga</surname><given-names>M</given-names></name><name><surname>Harsanyi</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>ESPEN guidelines on enteral nutrition: surgery including organ transplantation</article-title>. <source>Clin Nutr</source>
<year>2006</year>;<volume>25</volume>:<fpage>224</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">16698152</pub-id></mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barlow</surname><given-names>R</given-names></name><name><surname>Price</surname><given-names>P</given-names></name><name><surname>Reid</surname><given-names>TD</given-names></name><etal/></person-group>
<article-title>Prospective multicentre randomised controlled trial of early enteral nutrition for patients undergoing major upper gastrointestinal surgical resection</article-title>. <source>Clin Nutr</source>
<year>2011</year>;<volume>30</volume>:<fpage>560</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">21601319</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Brito-Ashurst</surname><given-names>I</given-names></name><name><surname>Preiser</surname><given-names>J-C</given-names></name></person-group>
<article-title>Diarrhea in critically ill patients: the role of enteral feeding</article-title>. <source>J Parenter Enteral Nutr</source>
<year>2016</year>;<volume>40</volume>:<fpage>913</fpage>&#x02013;<lpage>23</lpage>.</mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamberlan</surname><given-names>P</given-names></name><name><surname>Delgado</surname><given-names>AF</given-names></name><name><surname>Leone</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Nutrition therapy in a pediatric intensive care unit</article-title>. <source>J Parenter Enteral Nutr</source>
<year>2011</year>;<volume>35</volume>:<fpage>523</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halmos</surname><given-names>EP</given-names></name><name><surname>Gibson</surname><given-names>PR</given-names></name><name><surname>Muir</surname><given-names>JG</given-names></name></person-group>
<article-title>Contributing factors to diarrhoea in enteral nutrition</article-title>. <source>J Gastroenterol Hepatol</source>
<year>2009</year>;<volume>24</volume>:<fpage>A326</fpage>&#x02013;<lpage>1326</lpage>.</mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whelan</surname><given-names>K</given-names></name><name><surname>Judd</surname><given-names>PA</given-names></name><name><surname>Taylor</surname><given-names>MA</given-names></name></person-group>
<article-title>Diarrhea during enteral nutrition&#x02014;appropriate outcome measurement</article-title>. <source>Nutrition</source>
<year>2002</year>;<volume>18</volume>:<fpage>790</fpage>.<pub-id pub-id-type="pmid">12297227</pub-id></mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiesen</surname><given-names>P</given-names></name><name><surname>Van Gossum</surname><given-names>A</given-names></name><name><surname>Preiser</surname><given-names>JC</given-names></name></person-group>
<article-title>Diarrhoea in the critically ill</article-title>. <source>Curr Opin Crit Care</source>
<year>2006</year>;<volume>12</volume>:<fpage>149</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">16543792</pub-id></mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNaught</surname><given-names>CE</given-names></name><name><surname>Woodcock</surname><given-names>NP</given-names></name><name><surname>Anderson</surname><given-names>AD</given-names></name><etal/></person-group>
<article-title>A prospective randomised trial of probiotics in critically ill patients</article-title>. <source>Clin Nutr</source>
<year>2005</year>;<volume>24</volume>:<fpage>211</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">15784480</pub-id></mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majid</surname><given-names>HBA</given-names></name><name><surname>Cole</surname><given-names>J</given-names></name><name><surname>Sherry</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>A multi-centre, randomised, double-blind, controlled trial determining the effect of additional fructo-oligosaccharides on fecal microbiota and short-chain fatty acids among critical care patients receiving enteral nutrition</article-title>. <source>Gastroenterology</source>
<year>2012</year>;<volume>142</volume>:<fpage>S909</fpage>&#x02013;<lpage>1909</lpage>.</mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>SH</given-names></name><name><surname>Gerding</surname><given-names>DN</given-names></name><name><surname>Johnson</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Clinical practice guidelines for <italic>Clostridium difficile</italic> infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)</article-title>. <source>Infect Control Hosp Epidemiol</source>
<year>2010</year>;<volume>31</volume>:<fpage>431</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">20307191</pub-id></mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jack</surname><given-names>L</given-names></name><name><surname>Coyer</surname><given-names>F</given-names></name><name><surname>Courtney</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Diarrhoea risk factors in enterally tube fed critically ill patients: a retrospective audit</article-title>. <source>Intensive Crit Care Nurs</source>
<year>2010</year>;<volume>26</volume>:<fpage>327</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">21087731</pub-id></mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redman</surname><given-names>MG</given-names></name><name><surname>Ward</surname><given-names>EJ</given-names></name><name><surname>Phillips</surname><given-names>RS</given-names></name></person-group>
<article-title>The efficacy and safety of probiotics in people with cancer: a systematic review</article-title>. <source>Ann Oncol</source>
<year>2014</year>;<volume>25</volume>:<fpage>1919</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">24618152</pub-id></mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whelan</surname><given-names>K</given-names></name><name><surname>Judd</surname><given-names>PA</given-names></name><name><surname>Tuohy</surname><given-names>KM</given-names></name><etal/></person-group>
<article-title>Fecal microbiota in patients receiving enteral feeding are highly variable and may be altered in those who develop diarrhea</article-title>. <source>Am J Clin Nutr</source>
<year>2009</year>;<volume>89</volume>:<fpage>240</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">19056551</pub-id></mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whelan</surname><given-names>K</given-names></name><name><surname>Judd</surname><given-names>PA</given-names></name><name><surname>Preedy</surname><given-names>VR</given-names></name><etal/></person-group>
<article-title>Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans</article-title>. <source>J Nutr</source>
<year>2005</year>;<volume>135</volume>:<fpage>1896</fpage>&#x02013;<lpage>902</lpage>.<pub-id pub-id-type="pmid">16046714</pub-id></mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whelan</surname><given-names>K</given-names></name><name><surname>Schneider</surname><given-names>SM</given-names></name></person-group>
<article-title>Mechanisms, prevention, and management of diarrhea in enteral nutrition</article-title>. <source>Curr Opin Gastroenterol</source>
<year>2011</year>;<volume>27</volume>:<fpage>152</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">21191288</pub-id></mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spapen</surname><given-names>H</given-names></name><name><surname>Diltoer</surname><given-names>M</given-names></name><name><surname>Van Malderen</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Soluble fiber reduces the incidence of diarrhea in septic patients receiving total enteral nutrition: a prospective, double-blind, randomized, and controlled trial</article-title>. <source>Clin Nutr</source>
<year>2001</year>;<volume>20</volume>:<fpage>301</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">11478826</pub-id></mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rushdi</surname><given-names>TA</given-names></name><name><surname>Pichard</surname><given-names>C</given-names></name><name><surname>Khater</surname><given-names>YH</given-names></name></person-group>
<article-title>Control of diarrhea by fiber-enriched diet in ICU patients on enteral nutrition: a prospective randomized controlled trial</article-title>. <source>Clin Nutr</source>
<year>2004</year>;<volume>23</volume>:<fpage>1344</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">15556256</pub-id></mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>del Olmo</surname><given-names>D</given-names></name><name><surname>L&#x000f3;pez del Val</surname><given-names>T</given-names></name><name><surname>Mart&#x000ed;nez de Icaya</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Fibre in enteral nutrition: systematic review of the literature</article-title>. <source>Nutr Hosp</source>
<year>2004</year>;<volume>7</volume>:<fpage>167</fpage>&#x02013;<lpage>74</lpage>.</mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Application of dietary fiber in clinical enteral nutrition: a meta-analysis of randomized controlled trials</article-title>. <source>World J Gastroenterol</source>
<year>2005</year>;<volume>11</volume>:<fpage>3935</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">15991297</pub-id></mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goulet</surname><given-names>O</given-names></name></person-group>
<article-title>Potential role of the intestinal microbiota in programming health and disease</article-title>. <source>Nutr Rev</source>
<year>2015</year>;<volume>73</volume><issue>suppl 1</issue>:<fpage>32</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">26175488</pub-id></mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>V</given-names></name><name><surname>Garg</surname><given-names>R</given-names></name></person-group>
<article-title>Probiotics</article-title>. <source>Indian J Med Microbiol</source>
<year>2009</year>;<volume>27</volume>:<fpage>202</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">19584499</pub-id></mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teitelbaum</surname><given-names>JE</given-names></name></person-group>
<article-title>Probiotics and the treatment of infectious diarrhea</article-title>. <source>Pediatr Infect Dis J</source>
<year>2005</year>;<volume>24</volume>:<fpage>267</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">15750466</pub-id></mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>HC</given-names></name><name><surname>Hsu</surname><given-names>CH</given-names></name><name><surname>Chen</surname><given-names>HL</given-names></name><etal/></person-group>
<article-title>Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial</article-title>. <source>Pediatrics</source>
<year>2008</year>;<volume>122</volume>:<fpage>693</fpage>&#x02013;<lpage>700</lpage>.<pub-id pub-id-type="pmid">18829790</pub-id></mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whelan</surname><given-names>K</given-names></name></person-group>
<article-title>Enteral-tube-feeding diarrhoea: manipulating the colonic microbiota with probiotics and prebiotics</article-title>. <source>Proc Nutr Soc</source>
<year>2007</year>;<volume>66</volume>:<fpage>299</fpage>&#x02013;<lpage>306</lpage>.<pub-id pub-id-type="pmid">17637081</pub-id></mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrie</surname><given-names>S</given-names></name><name><surname>Daley</surname><given-names>M</given-names></name></person-group>
<article-title>Lactobacillus GG as treatment for diarrhea during enteral feeding in critical illness: randomized controlled trial</article-title>. <source>J Parenter Enteral Nutr</source>
<year>2011</year>;<volume>35</volume>:<fpage>43</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>SJ</given-names></name></person-group>
<article-title>The potential of probiotics to prevent <italic>Clostridium difficile</italic> infection</article-title>. <source>Infect Dis Clin North Am</source>
<year>2015</year>;<volume>29</volume>:<fpage>135</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">25677707</pub-id></mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobin</surname><given-names>LH</given-names></name><name><surname>Compton</surname><given-names>CC</given-names></name></person-group>
<article-title>TNM seventh edition: what's new, what's changed communication from the International Union Against Cancer and the American Joint Committee on Cancer</article-title>. <source>Cancer</source>
<year>2010</year>;<volume>116</volume>:<fpage>5336</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">20665503</pub-id></mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weimann</surname><given-names>A</given-names></name><name><surname>Braga</surname><given-names>M</given-names></name><name><surname>Carli</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>ESPEN guideline: clinical nutrition in surgery</article-title>. <source>Clin Nutr</source>
<year>2017</year>;<volume>36</volume>:<fpage>623</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">28385477</pub-id></mixed-citation></ref><ref id="R31"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whelan</surname><given-names>K</given-names></name><name><surname>Judd</surname><given-names>PA</given-names></name><name><surname>Taylor</surname><given-names>MA</given-names></name></person-group>
<article-title>Assessment of fecal output in patients receiving enteral tube feeding: validation of a novel chart</article-title>. <source>Eur J Clin Nutr</source>
<year>2004</year>;<volume>58</volume>:<fpage>1030</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">15220945</pub-id></mixed-citation></ref><ref id="R32"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whelan</surname><given-names>K</given-names></name><name><surname>Judd</surname><given-names>PA</given-names></name><name><surname>Preedy</surname><given-names>VR</given-names></name><etal/></person-group>
<article-title>Covert assessment of concurrent and construct validity of a chart to characterize fecal output and diarrhea in patients receiving enteral nutrition</article-title>. <source>J Parenter Enteral Nutr</source>
<year>2008</year>;<volume>32</volume>:<fpage>160</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="R33"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamarul</surname><given-names>ZM</given-names></name><name><surname>Chin</surname><given-names>KF</given-names></name><name><surname>Rai</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Fiber and prebiotic supplementation in enteral nutrition: a systematic review and meta-analysis</article-title>. <source>World J Gastroenterol</source>
<year>2015</year>;<volume>21</volume>:<fpage>5372</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">25954112</pub-id></mixed-citation></ref><ref id="R34"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McRorie</surname><given-names>JW</given-names></name><name><surname>McKeown</surname><given-names>NM</given-names></name></person-group>
<article-title>Understanding the physics of functional fibers in the gastrointestinal tract: an evidence-based approach to resolving enduring misconceptions about insoluble and soluble fiber</article-title>. <source>J Acad Nutr Diet</source>
<year>2017</year>;<volume>117</volume>:<fpage>251</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">27863994</pub-id></mixed-citation></ref><ref id="R35"><label>[35]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayes</surname><given-names>N</given-names></name><name><surname>Hansen</surname><given-names>S</given-names></name><name><surname>Seehofer</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery</article-title>. <source>Nutrition</source>
<year>2002</year>;<volume>18</volume>:<fpage>609</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">12093440</pub-id></mixed-citation></ref><ref id="R36"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>NT</given-names></name></person-group>
<article-title>Probiotics</article-title>. <source>Am J Health Syst Pharm</source>
<year>2010</year>;<volume>67</volume>:<fpage>449</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="pmid">20208051</pub-id></mixed-citation></ref><ref id="R37"><label>[37]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saad</surname><given-names>N</given-names></name><name><surname>Delattre</surname><given-names>C</given-names></name><name><surname>Urdaci</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>An overview of the last advances in probiotic and prebiotic field</article-title>. <source>LWT Food Sci Technol</source>
<year>2013</year>;<volume>50</volume>:<fpage>1</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="R38"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chittawatanarat</surname><given-names>K</given-names></name><name><surname>Pokawinpudisnun</surname><given-names>P</given-names></name><name><surname>Polbhakdee</surname><given-names>Y</given-names></name></person-group>
<article-title>Mixed fibers diet in surgical ICU septic patients</article-title>. <source>Asia Pac J Clin Nutr</source>
<year>2010</year>;<volume>19</volume>:<fpage>458</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">21147705</pub-id></mixed-citation></ref><ref id="R39"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halmos</surname><given-names>EP</given-names></name></person-group>
<article-title>Role of FODMAP content in enteral nutrition-associated diarrhea</article-title>. <source>J Gastroenterol Hepatol</source>
<year>2013</year>;<volume>28</volume>:<fpage>25</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">24251699</pub-id></mixed-citation></ref><ref id="R40"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klosterbuer</surname><given-names>A</given-names></name><name><surname>Roughead</surname><given-names>ZF</given-names></name><name><surname>Slavin</surname><given-names>J</given-names></name></person-group>
<article-title>Benefits of dietary fiber in clinical nutrition</article-title>. <source>Nutr Clin Pract</source>
<year>2011</year>;<volume>26</volume>:<fpage>625</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">21947646</pub-id></mixed-citation></ref><ref id="R41"><label>[41]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slavin</surname><given-names>J</given-names></name></person-group>
<article-title>Fiber and prebiotics: mechanisms and health benefits</article-title>. <source>Nutrients</source>
<year>2013</year>;<volume>5</volume>:<fpage>1417</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">23609775</pub-id></mixed-citation></ref><ref id="R42"><label>[42]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mowat</surname><given-names>AM</given-names></name><name><surname>Agace</surname><given-names>WW</given-names></name></person-group>
<article-title>Regional specialization within the intestinal immune system</article-title>. <source>Nat Rev Immunol</source>
<year>2014</year>;<volume>14</volume>:<fpage>667</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">25234148</pub-id></mixed-citation></ref><ref id="R43"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hustoft</surname><given-names>TN</given-names></name><name><surname>Hausken</surname><given-names>T</given-names></name><name><surname>Ystad</surname><given-names>SO</given-names></name><etal/></person-group>
<article-title>Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome</article-title>. <source>Neurogastroenterol Motil</source>
<year>2016</year>;<volume>29</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="R44"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koruda</surname><given-names>MJ</given-names></name><name><surname>Rolandelli</surname><given-names>RH</given-names></name><name><surname>Bliss</surname><given-names>DZ</given-names></name><etal/></person-group>
<article-title>Parenteral-nutrition supplemented with short-chain fatty-acids&#x02014;effect on the small-bowel mucosa in normal rats</article-title>. <source>Am J Clin Nutr</source>
<year>1990</year>;<volume>51</volume>:<fpage>685</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">1690948</pub-id></mixed-citation></ref><ref id="R45"><label>[45]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arboleya</surname><given-names>S</given-names></name><name><surname>Salazar</surname><given-names>N</given-names></name><name><surname>Sol&#x000ed;s</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>In vitro evaluation of the impact of human background microbiota on the response to Bifidobacterium strains and fructo-oligosaccharides</article-title>. <source>Br J Nutr</source>
<year>2013</year>;<volume>110</volume>:<fpage>2030</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">23721811</pub-id></mixed-citation></ref><ref id="R46"><label>[46]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Hara</surname><given-names>AM</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name></person-group>
<article-title>Gut microbiota: mining for therapeutic potential</article-title>. <source>Clin Gastroenterol Hepatol</source>
<year>2007</year>;<volume>5</volume>:<fpage>274</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">17368226</pub-id></mixed-citation></ref><ref id="R47"><label>[47]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quigley</surname><given-names>EMM</given-names></name></person-group>
<article-title>Prebiotics and probiotics</article-title>. <source>Nutr Clin Pract</source>
<year>2011</year>;<volume>27</volume>:<fpage>195</fpage>&#x02013;<lpage>200</lpage>.<pub-id pub-id-type="pmid">22127952</pub-id></mixed-citation></ref><ref id="R48"><label>[48]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koecher</surname><given-names>KJ</given-names></name><name><surname>Thomas</surname><given-names>W</given-names></name><name><surname>Slavin</surname><given-names>JL</given-names></name></person-group>
<article-title>Healthy subjects experience bowel changes on enteral diets: addition of a fiber blend attenuates stool weight and gut bacteria decreases without changes in gas</article-title>. <source>J Parenter Enteral Nutr</source>
<year>2015</year>;<volume>39</volume>:<fpage>337</fpage>&#x02013;<lpage>43</lpage>.</mixed-citation></ref><ref id="R49"><label>[49]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>JM</given-names></name></person-group>
<article-title>Immunomodulatory mechanisms of lactobacilli</article-title>. <source>Microb Cell Fact</source>
<year>2011</year>;<volume>10</volume><issue>suppl 1</issue>:<fpage>S17</fpage>.<pub-id pub-id-type="pmid">21995674</pub-id></mixed-citation></ref><ref id="R50"><label>[50]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerritsen</surname><given-names>J</given-names></name><name><surname>Smidt</surname><given-names>H</given-names></name><name><surname>Rijkers</surname><given-names>GT</given-names></name><etal/></person-group>
<article-title>Intestinal microbiota in human health and disease: the impact of probiotics</article-title>. <source>Genes Nutr</source>
<year>2011</year>;<volume>6</volume>:<fpage>209</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">21617937</pub-id></mixed-citation></ref><ref id="R51"><label>[51]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlasova</surname><given-names>AN</given-names></name><name><surname>Kandasamy</surname><given-names>S</given-names></name><name><surname>Chattha</surname><given-names>KS</given-names></name><etal/></person-group>
<article-title>Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species</article-title>. <source>Vet Immunol Immunopathol</source>
<year>2016</year>;<volume>172</volume>:<fpage>72</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">26809484</pub-id></mixed-citation></ref><ref id="R52"><label>[52]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakao</surname><given-names>M</given-names></name><name><surname>Ogura</surname><given-names>Y</given-names></name><name><surname>Satake</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Usefulness of soluble dietary fiber for the treatment of diarrhea during enteral nutrition in elderly patients</article-title>. <source>Nutrition</source>
<year>2002</year>;<volume>18</volume>:<fpage>35</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">11827762</pub-id></mixed-citation></ref><ref id="R53"><label>[53]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takesue</surname><given-names>Y</given-names></name><name><surname>Yokoyama</surname><given-names>T</given-names></name><name><surname>Akagi</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Changes in the intestinal flora after the administration of prophylactic antibiotics to patients undergoing a gastrectomy</article-title>. <source>Surg Today</source>
<year>2002</year>;<volume>32</volume>:<fpage>581</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">12111513</pub-id></mixed-citation></ref><ref id="R54"><label>[54]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aron-Wisnewsky</surname><given-names>J</given-names></name><name><surname>Clement</surname><given-names>K</given-names></name></person-group>
<article-title>The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity</article-title>. <source>Curr Atheroscler Rep</source>
<year>2014</year>;<volume>16</volume>:<fpage>454</fpage>.<pub-id pub-id-type="pmid">25214424</pub-id></mixed-citation></ref><ref id="R55"><label>[55]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawas</surname><given-names>T</given-names></name><name><surname>Al Halabi</surname><given-names>S</given-names></name><name><surname>Hernaez</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Patients receiving prebiotics and probiotics before liver transplantation develop fewer infections than controls: a systematic review and meta-analysis</article-title>. <source>Clin Gastroenterol Hepatol</source>
<year>2015</year>;<volume>13</volume>:<fpage>1567</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">26044318</pub-id></mixed-citation></ref><ref id="R56"><label>[56]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruna Esteban</surname><given-names>M</given-names></name><name><surname>Vorwald</surname><given-names>P</given-names></name><name><surname>Ortega Lucea</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Enhanced recovery after surgery in gastric resections</article-title>. <source>Cir Esp</source>
<year>2017</year>;<volume>95</volume>:<fpage>73</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">28185641</pub-id></mixed-citation></ref></ref-list></back></article>